Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LLY compared with PVLA: revenue, margins and what each company keeps, and the suppliers and customers both name
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
PVLA
Palvella Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
LLY
ELI Lilly & Co
vs
PVLA
Palvella Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only LLY
29
MCK
McKesson
customer
CAH
Cardinal Health
customer
VEEV
Veeva Systems
supplier
UTHR
United Therapeutics
customer
25 more · LLY chain
›
Shared
0
No disclosed counterparties: PVLA.
Only PVLA
0
None
Role chip = supplier or customer
Source: SEC EDGAR
LLY
ELI Lilly & Co
Change
1,371.32
▼
−3.29%
· post 1,363.77
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
PVLA
Palvella Therapeutics, Inc.
Change
156.51
▼
−3.55%
· post 156.53
Closed
Nov 5 '26
Mkt cap
—
Revenue
—
Revenue
—
vs
Compare
Closed
Nov 5 '26
LLY
ELI Lilly & Co
vs
PVLA
Palvella Therapeutics, Inc.
1,371.32
▼
−3.29%
post 1,363.77
Price
156.51
▼
−3.55%
post 156.53
$1.3T
Mkt cap
—
Q3 FY26
$24.4B
Revenue
—
FY25
$65.2B
Revenue
—
Change
Change
LLY
1,371.32
▼
−3.29%
vs
PVLA
156.51
▼
−3.55%
Closed
Nov 5 '26